Abstract
PurposeRadiotherapy (RT) is an integral component in the management of many abdominal and pelvic malignancies. Imaging follow-up in patients who have received RT is performed to assess for treatment response, evaluate for tumour recurrence and to diagnose complications related to treatment. The purpose of this pictorial review is to depict the expected imaging findings and potential complications following RT in the genitourinary (GU) tract using an organ-based approach and to review the diagnosis of locally recurrent tumour in the GU tract following RT.ConclusionsSome GU malignancies, namely cervical and prostatic carcinoma, can be treated with radical RT with intent to cure. More frequently, the GU tract is indirectly treated as a result of RT to adjacent cancers. Expected imaging findings, RT-related complications and the diagnosis of recurrent tumour following RT in the GU tract often necessitate a multi-modality imaging approach, the incorporation of functional imaging techniques and an organ-based approach for diagnosis.
Highlights
Radiotherapy (RT) is commonly used for the treatment of various malignancies in the abdomen and pelvis
GU involvement can be direct or indirect
Imaging findings with magnetic resonance imaging (MRI) are similar, early changes of RT-induced cystitis are better depicted with T2-weighted sequences, which demonstrate variable degrees of increased signal in the bladder wall depending on the severity of the injury [9, 14]
Summary
Radiotherapy (RT) is commonly used for the treatment of various malignancies in the abdomen and pelvis. RT-related complications and the diagnosis of recurrent tumour following RT in the GU tract often necessitate a multi-modality imaging approach, the incorporation of functional imaging techniques and an organ-based approach for diagnosis. Radiation nephropathy results in atrophy and scarring of the renal cortex with a smooth contour (Fig. 2) [10]; imaging findings indicative of irreversible damage.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have